Cervical Cancer Screening: Current Practices and Future Perspectives
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 1 October 2026 | Viewed by 4025
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cervical carcinoma is caused by a persistent high-risk human papillomavirus (HPV) infection. This scientifically proven statement has led, in recent decades, to the development of two very important innovations, i.e., the HPV vaccine and the HPV-based cervical cancer screening. The latter refers to the implementation of various screening tests, developed and validated in large-scale trials, based on the detection of HPV nucleic acids, into organized cervical cancer screening.
In 2018, the WHO launched a strategy for the elimination of cervical cancer utilizing the abovementioned tools and novel advancements regarding the treatment of invasive cervical cancer. This strategy is based on three goals, namely, the achievement of a 90% coverage of girls up to the age of 15 with the vaccine against HPV, the coverage of 70% of women with a high-performance HPV-based screening test twice in their lifetime, and the proper treatment of at least 90% of women diagnosed with cervical (pre)cancer.
This Special Issue will be dedicated to the second pillar of the WHO goals for cervical cancer elimination, i.e., to cervical cancer secondary prevention or cervical cancer screening, and will accept manuscripts investigating, but not being limited to, the following:
- The performance of screening algorithms;
- Novel screening modalities (for primary screening or triage);
- Self-sampling;
- Modelling on the projection of screening in the context of HPV vaccination;
- Screening for underserved populations;
- Screening for immunocompromised populations;
- Screening for populations vaccinated against HPV;
- Performance of AI-assisted colposcopy;
- Cervical precancer treatment and follow-up.
I strongly encourage researchers in basic science, public health, or clinical science involved with HPV, cervical disease, and screening to submit their work to be included in this Special Issue; I hope that in this way we will be able to produce a collection of scientific publications presenting up-to-date and innovative research, which would reflect the present and future landscape of cervical cancer screening, from a multi-disciplinary perspective.
Dr. Kimon Chatzistamatiou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer screening
- cervical carcinogenesis
- human papillomavirus
- HPV primary screening
- self-sampling
- triage of HPV-positive
- post-conization follow-up
- screening for immunocompromised women
- screening for vac-cinated women
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
